BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 9644986)

  • 1. [Effects of antihypertensive therapy on renal function in nephrogenic hypertension].
    Figarov IG; Dzhavad-Zade SM
    Urol Nefrol (Mosk); 1998; (3):27-9. PubMed ID: 9644986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of antihypertensive and metabolic effects of lisinopril 20 mg/hydrochlorothiazide 12.5 mg fixed combination and captopril 50 mg/hydrochlorothiazide 25 mg fixed combination].
    Milon H; Baleydier A
    Therapie; 1997; 52(3):195-205. PubMed ID: 9366103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antihypertensive action of indapamide in hypertension of chronic renal failure].
    Meyrier A; Condamin MC
    Ann Cardiol Angeiol (Paris); 1994 Jan; 43(1):43-8. PubMed ID: 8172477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.
    Dezii CM
    Manag Care; 2001 Feb; 10(2 Suppl):6-10. PubMed ID: 11729406
    [No Abstract]   [Full Text] [Related]  

  • 8. Antihypertensive therapy in renal patients - benefits and difficulties.
    Schwenger V; Zeier M; Ritz E
    Nephron; 1999; 83(3):202-13. PubMed ID: 10529626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.
    Dussol B; Moussi-Frances J; Morange S; Somma-Delpero C; Mundler O; Berland Y
    Nephrol Dial Transplant; 2005 Feb; 20(2):349-53. PubMed ID: 15615808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
    Filatova EV; Vikhert OA; Rogoza AN; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1996; 68(5):67-70. PubMed ID: 9082606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed combination therapy of hypertension: focus on valsartan/hydrochlorothiazide combination (Diovan/HCT).
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2003 Sep; 1(3):335-43. PubMed ID: 15030262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive and hypokalemic effects of isobutyl hydrochlorothiazide alone and in combination with spironolactone.
    Lochaya S; Suvachittanont O; Triyanond K
    J Med Assoc Thai; 1985 Aug; 68(8):399-407. PubMed ID: 3906011
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diuretics and antihypertensive agents in chronic kidney insufficiency: comparison of the effects of metolazone and furosemide].
    Groth H; Vetter H; Achermann R; Kuhlmann U; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1985 Jan; 115(2):41-5. PubMed ID: 3969541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lethal polypharmacy in a patient with arterial hypertension--re the article from DMW 50/2004].
    Werner H
    Dtsch Med Wochenschr; 2005 Feb; 130(8):413; author reply 413-4. PubMed ID: 15717254
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of the ACE-inhibitor captopril on the blood pressure and kidney function of patients with essential and renal hypertension].
    Jansa U; Stein G; Günther K
    Z Gesamte Inn Med; 1991 Dec; 46(17):642-7. PubMed ID: 1776307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Davis BR; Whelton PK;
    N Engl J Med; 2009 Mar; 360(11):1148-9; author reply 1149-50. PubMed ID: 19283889
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.